mRNA vaccines work by delivering genetic instructions to cells, prompting them to produce specific proteins. In the case of cancer, these proteins are often tumor-associated antigens (TAAs), which are recognized by the immune system as foreign. The immune system then targets cells expressing these antigens, aiming to eliminate cancer cells.
